Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders: a Single-Site Pilot Study

NCT05649098 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05649098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders: a Single-Site Pilot Study
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Recruiting
Start date
June 12, 2023
Completion date
June 1, 2032
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin diseases